Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06420531 · ClinicalTrials.gov registry record · NA

Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

A NA study of Prematurity, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
486
Enrollment target
4
Study locations

NCT06420531 is a NA study of Prematurity that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 486 participants, above the 188-participant average among 21 other Prematurity trials with a reported enrollment target (159% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06420531, a NA study of Prematurity, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
486 participants
Enrollment target
4
Study locations

Study Summary

The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Human milk

Study Locations (4)

Texas

  • University of Texas Southwestern Medical Center at Dallas - Dallas
  • University of Texas Health Science Center at Houston - Houston

Alabama

  • University of Alabama at Birmingham - Birmingham

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 486 participants
Start Date 2025-09-16
Est. Completion 2030-08-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06420531

The ClinicalTrials.gov registry entry for NCT06420531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 486 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 188-participant average among 21 other Prematurity trials with a reported enrollment target (159% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Human milk is the first listed.

NCT06420531 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Texas, Alabama, Mississippi.

Frequently Asked Questions

What is clinical trial NCT06420531 about?

NCT06420531 is a clinical study titled "Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial". The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.

What is the current status of trial NCT06420531?

This trial is currently recruiting. It is a NA study. The enrollment target is 486 participants. The study started on 2025-09-16. Estimated completion is 2030-08-30.

What conditions does trial NCT06420531 study?

This clinical trial studies the following conditions: Prematurity.

What interventions are being tested in trial NCT06420531?

The interventions under investigation include: Human milk (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06420531?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06420531 being conducted?

This trial has 4 study locations across Alabama, Mississippi, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.